Cho E, Choe Y
Clin Exp Pediatr. 2021; 64(7):322-327.
PMID: 34082502
PMC: 8255509.
DOI: 10.3345/cep.2021.00353.
Althwanay A, Ahsan F, Oliveri F, Goud H, Mehkari Z, Mohammed L
Cureus. 2020; 12(10):e10775.
PMID: 33154845
PMC: 7606206.
DOI: 10.7759/cureus.10775.
Cetin C, Kara A
Turk J Med Sci. 2020; 50(SI-1):527-533.
PMID: 32299207
PMC: 7195981.
DOI: 10.3906/sag-2004-175.
Nidzworski D, Dobkowska J, Holysz M, Gromadzka B, Szewczyk B
Cent Eur J Biol. 2020; 9(6):628-633.
PMID: 32215120
PMC: 7088769.
DOI: 10.2478/s11535-014-0296-z.
Huang S, Huang W, Chen Y, Tsai C, Lee I
Am J Trop Med Hyg. 2017; 97(6):1945-1951.
PMID: 29016325
PMC: 5805038.
DOI: 10.4269/ajtmh.17-0172.
Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection.
Timin A, Muslimov A, Petrova A, Lepik K, Okilova M, Vasin A
Sci Rep. 2017; 7(1):102.
PMID: 28273907
PMC: 5427965.
DOI: 10.1038/s41598-017-00200-0.
In silico virtual screening approaches for anti-viral drug discovery.
Murgueitio M, Bermudez M, Mortier J, Wolber G
Drug Discov Today Technol. 2014; 9(3):e219-25.
PMID: 24990575
PMC: 7105918.
DOI: 10.1016/j.ddtec.2012.07.009.
Influenza: a scientometric and density-equalizing analysis.
Fricke R, Uibel S, Klingelhoefer D, Groneberg D
BMC Infect Dis. 2013; 13:454.
PMID: 24079616
PMC: 3851602.
DOI: 10.1186/1471-2334-13-454.
Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty.
Ndeffo Mbah M, Medlock J, Meyers L, Galvani A, Townsend J
Vaccine. 2013; 31(30):3079-89.
PMID: 23684837
PMC: 3764605.
DOI: 10.1016/j.vaccine.2013.04.052.
Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic.
Basurto-Davila R, Garza R, Meltzer M, Carlino O, Albalak R, Orellano P
Influenza Other Respir Viruses. 2012; 7(6):1308-15.
PMID: 23176127
PMC: 4634266.
DOI: 10.1111/irv.12054.
Monoclonal antibodies targeting the synthetic peptide corresponding to the polybasic cleavage site on H5N1 influenza hemagglutinin.
Tsai H, Chi L, Yu A
J Biomed Sci. 2012; 19:37.
PMID: 22471562
PMC: 3366877.
DOI: 10.1186/1423-0127-19-37.
Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung.
Dienz O, Rud J, Eaton S, Lanthier P, Burg E, Drew A
Mucosal Immunol. 2012; 5(3):258-66.
PMID: 22294047
PMC: 3328598.
DOI: 10.1038/mi.2012.2.
Lysosome-associated membrane glycoprotein 3 is involved in influenza A virus replication in human lung epithelial (A549) cells.
Zhou Z, Xue Q, Wan Y, Yang Y, Wang J, Hung T
Virol J. 2011; 8:384.
PMID: 21810281
PMC: 3162545.
DOI: 10.1186/1743-422X-8-384.
Pandemic influenza: implications for preparation and delivery of critical care services.
Manuell M, Co M, Ellison 3rd R
J Intensive Care Med. 2011; 26(6):347-67.
PMID: 21220275
PMC: 4110744.
DOI: 10.1177/0885066610393314.
High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity.
Su C, Cheng T, Lin M, Wang S, Huang W, Lin-Chu S
Proc Natl Acad Sci U S A. 2010; 107(45):19151-6.
PMID: 20974907
PMC: 2984200.
DOI: 10.1073/pnas.1013592107.
A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly.
Fragapane E, Gasparini R, Schioppa F, Laghi-Pasini F, Montomoli E, Banzhoff A
Clin Vaccine Immunol. 2010; 17(11):1817-9.
PMID: 20810680
PMC: 2976095.
DOI: 10.1128/CVI.00461-09.
Influenza in refugees on the Thailand-Myanmar border, May-October 2009.
Turner P, Turner C, Watthanaworawit W, Carrara V, Kapella B, Painter J
Emerg Infect Dis. 2010; 16(9):1366-72.
PMID: 20735919
PMC: 3294974.
DOI: 10.3201/eid1609.100220.
Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.
Operario D, Moser M, St George K
J Clin Microbiol. 2010; 48(10):3517-24.
PMID: 20668122
PMC: 2953111.
DOI: 10.1128/JCM.01031-10.
Influenza: the once and future pandemic.
Taubenberger J, Morens D
Public Health Rep. 2010; 125 Suppl 3:16-26.
PMID: 20568566
PMC: 2862331.
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Brass A, Huang I, Benita Y, John S, Krishnan M, Feeley E
Cell. 2010; 139(7):1243-54.
PMID: 20064371
PMC: 2824905.
DOI: 10.1016/j.cell.2009.12.017.